THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma

Agavni Mesropian; Albert Gris‐Oliver; Ugne Balaseviciute; Martí Torres-Marcen; Jordi Abril‐Fornaguera; Marta Piqué‐Gili; David Camell; Judit Peix; Elisa Fernández-Martínez; Júlia Huguet‐Pradell; Ieva Keraite; Roger Esteban-Fabró; Takayuki Kimura; Alka A. Potdar; Marina Bárcena‐Varela; Katherine E. Lindblad; Amaia Lujambio; Ernesto Guccione; Swan N. Thung; Daniela Sia; Roser Pinyol; Josep M. Llovet

doi:10.1016/s0168-8278(25)01237-1

Article2025

E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Agavni Mesropian, Albert Gris‐Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen, Martí Torres-Marcén, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, D. Camell-Raventós, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet‐Pradell, Ana Hernández de Sande, Ieva Keraite, Roger Esteban-Fabró, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Masafumi Ikeda, Masatoshi Kudo, Daniela Sia, Roser Pinyol, Josep M. Llovet

Article2025

Data from E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Agavni Mesropian, Albert Gris‐Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen, Martí Torres-Marcén, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, D. Camell-Raventós, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet‐Pradell, Ana Hernández de Sande, Ieva Keraite, Roger Esteban-Fabró, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Masafumi Ikeda, Masatoshi Kudo,

Article2025

Supplementary Data 1 from E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Agavni Mesropian, Albert Gris‐Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen, Martí Torres-Marcén, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, D. Camell-Raventós, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet‐Pradell, Ana Hernández de Sande, Ieva Keraite, Roger Esteban-Fabró, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Masafumi Ikeda, Masatoshi Kudo,

Article2024

76 (PB064): E7386 enhances both lenvatinib and anti-PD1 antitumor activity in HCC

A. Mesropian Badalian, Albert Gris‐Oliver, Jordi Abril‐Fornaguera, Marta Piqué‐Gili, M. Torres-Marcén, D. Camell-Raventós, Judit Peix, Eduardo Fernández‐Martínez, Ugne Balaseviciute, Júlia Huguet‐Pradell, Ieva Keraite, Roger Esteban-Fabró, Roser Pinyol, Marina Bárcena‐Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan N. Thung, Daniela Sia, Josep M. Llovet

European Journal of Cancer

Article2025

TOP-128-YI Efficacy of WNTinib, a novel selective therapeutic for CTNNB1mutant tumors, in preclinical models of hepatoblastoma

Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Elisa Fernández-Martínez, Albert Gris‐Oliver, Roser Pinyol, Alex Rialdi, Agavni Mesropian, Gulay Ulukaya, Dan Hasson, Ieva Keraite, Swan N. Thung, Ernesto Guccione, Josep M. Llovet

Journal of Hepatology

THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma

Abstract

Discussion(0)

Related publications

E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Data from E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Supplementary Data 1 from E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

76 (PB064): E7386 enhances both lenvatinib and anti-PD1 antitumor activity in HCC

TOP-128-YI Efficacy of WNTinib, a novel selective therapeutic for CTNNB1mutant tumors, in preclinical models of hepatoblastoma